Results 211 to 220 of about 830,526 (356)

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia   +4 more
wiley   +1 more source

Urologic Issues in LGBT Health [PDF]

open access: yes, 2016
Breyer, Benjamin N   +2 more
core   +1 more source

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching   +20 more
wiley   +1 more source

Leiomyosarcoma of lower urinary tract: Literature review. [PDF]

open access: yesCent European J Urol
Settaf-Cherif L   +8 more
europepmc   +1 more source

Machine Learning-Assistant Colorimetric Sensor Arrays for Intelligent and Rapid Diagnosis of Urinary Tract Infection

open access: green
Jianyu Yang   +11 more
openalex   +2 more sources

Сhronobiological features of females with symptoms of lower urinary tract

open access: diamond, 2020
V.A. Lanina   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy